Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07615725 · ClinicalTrials.gov registry record · NA

Dry Needling in Multiple Sclerosis

A NA study, sponsored by University of South Florida.

Recruiting
Registry status
NA
Development phase
24
Enrollment target

NCT07615725: Recruiting NA study, sponsored by University of South Florida.

NCT07615725 is a NA study that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07615725, a NA study, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

This study is placed at the Human Functional Performance Laboratory in the School of physical therapy and Rehabilitation Sciences (MDT building) at University of South Florida. The study is supported by Consortium of Multiple Sclerosis Centers. We are doing this study to see if a treatment called dry needling improves chronic pain in the lower limb (from the low back to the foot) in people who have Multiple Sclerosis. Dry needling involves using tiny needles, like those used in acupuncture, to target certain muscles, such as the thigh or calf muscles. It is different from traditional acupuncture because it focuses on treating specific muscle spots to reduce muscle stiffness and pain. Dry needling may help reduce your pain without any medication. We also hope to see whether dry needling helps improve balance and walking abilities, which may lead to better day-to-day functioning. In this study, there are two groups. In each group, participants will receive six sessions of dry needling. One group will receive actual dry needling, while the other group will receive a procedure that mimics dry needling. The treatment you get will be chosen by chance, like flipping a coin. Neither you nor the study doctor will choose what treatment you get. You will have an equal chance of being given either treatment or sham treatment. You will not be told which treatment you are getting; however your study doctor will know. You are being asked to take part because you have been diagnosed with Multiple Sclerosis and are experiencing long-lasting pain in your lower limbs, including the buttocks, thighs, calf, and foot. We want to find out if this treatment will help people with Multiple Sclerosis who have lower limb pain.

Interventions

  • PROCEDURE Dry Needling
  • PROCEDURE Sham Dry Needling

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2026-05-08
Est. Completion 2027-06-01
Phase NA
University of South Florida

252 total trials

What NCT07615725 shows while recruiting

NCT07615725 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Dry Needling is the first listed.

NCT07615725 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07615725 about?

NCT07615725 is a clinical study titled "Dry Needling in Multiple Sclerosis". This study is placed at the Human Functional Performance Laboratory in the School of physical therapy and Rehabilitation Sciences (MDT building) at University of South Florida. The study is supported by Consortium of Multiple Sclerosis Centers. We are doing this study to see if a treatment called dr...

What is the current status of trial NCT07615725?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-05-08. Estimated completion is 2027-06-01.

What interventions are being tested in trial NCT07615725?

The interventions under investigation include: Dry Needling (PROCEDURE), Sham Dry Needling (PROCEDURE).

Who is sponsoring clinical trial NCT07615725?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07615725's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07615725, the US trial registry maintained by the National Library of Medicine. NCT07615725 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.